Innovations in Drug Discovery: Trends Redefining Pharma R&D Kumar Jeetendra | May 6, 2026 Can gene editing be used as a life-saving treatment? Could antiviral drugs that target human proteins be more effective than those than target the viruses themselves? The constant evolution of drug discovery is one of the most exciting aspects of modern medicine, and new research is leading to breakthroughs in precision medicine, cancer immunotherapy, neurodegenerative …
Pharma News Today: Healthcare Breakthroughs in 2026 Kumar Jeetendra | May 19, 2026 2026 marks a new chapter for the pharmaceutical and healthcare sectors. New technologies in AI, next generation biotech, and precision medicine, paired with new scientific discoveries, will attempt to meet the growing global demand for next generation healthcare. Innovations that include advanced biomanufacturing and smarter diagnostics will create therapies in a fraction of the time …
Aragen to Manufacture Renaissance Pharma’s Fast-Track mAb Kumar Jeetendra | June 3, 2026 Aragen, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has successfully tech-transferred and manufactured the first commercial-scale GMP batches of Renaissance Pharma’s lead candidate, Daretabart – a humanized monoclonal antibody targeting GD2 for high-risk neuroblastoma – in just 9 months. The anti-GD2 monoclonal antibody received Fast Track Designation from the FDA in April 2026 for …
